Operating Income for Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's current operating income (TTM) is -$1.39B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
-$1.39B
YoY change
+71.5%
5Y CAGR
N/A
Peak year (2017)
-$31.13M
Cumulative operating income
-$3.04B
Operating Income history chart for Revolution Medicines (RVMD) from 2017 to 2025
Operating Income history table for Revolution Medicines (RVMD) from 2017 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | -$1.18B | +71.5% | -$492.85M | ||
| 2024 | -$689.52M | +41.5% | -$202.34M | ||
| 2023 | -$487.19M | +88.6% | -$228.91M | ||
| 2022 | -$258.28M | +37.4% | -$70.27M | ||
| 2021 | -$188.01M | +69.8% | -$77.31M | ||
| 2020 | -$110.70M | +104.5% | -$56.58M | ||
| 2019 | -$54.12M | +34.2% | -$13.79M | ||
| 2018 | -$40.33M | +29.6% | -$9.20M | ||
| 2017 | -$31.13M | — | — |
Operating Income values are taken from Revolution Medicines's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Revolution Medicines (RVMD) most recent annual operating income stands at -$1.18B (2025) – surged 71.5% year-over-year.
The dataset's maximum operating income sits at -$31.13M (2017); the minimum reading of -$1.18B dates to 2025.
Within Healthcare, Revolution Medicines (RVMD) ranks 9th among 8 peers we track. The peer median for operating income is $21.79B.
Revolution Medicines Operating Income by Year
Revolution Medicines Operating Income 2025: -$1.18B
Revolution Medicines operating income in 2025 was -$1.18B, surged 71.5% from 2024. This figure represents the lowest annual value in the available history.
Revolution Medicines Operating Income 2024: -$689.52M
Revolution Medicines operating income in 2024 was -$689.52M, surged 41.5% from 2023.
Revolution Medicines Operating Income 2023: -$487.19M
Revolution Medicines operating income in 2023 was -$487.19M, surged 88.6% from 2022.
Revolution Medicines Operating Income 2022: -$258.28M
Revolution Medicines operating income in 2022 was -$258.28M, surged 37.4% from 2021.
Revolution Medicines Operating Income 2021: -$188.01M
Revolution Medicines operating income in 2021 was -$188.01M.
See more financial history for Revolution Medicines (RVMD).
Sector peers — Operating Income
Companies in the same sector as Revolution Medicines, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk (NVO) | $127.66B | Healthcare |
| Eli Lilly (LLY) | $29.70B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| Merck & Co. (MRK) | $23.49B | Healthcare |
| AbbVie (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group (UNH) | $18.96B | Healthcare |
| AstraZeneca (AZN) | $13.74B | Healthcare |
| Amgen (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Revolution Medicines's operating income?
Latest reported operating income for Revolution Medicines (RVMD) is -$1.39B (period ending March 31, 2026).
How has Revolution Medicines operating income changed year-over-year?
Revolution Medicines (RVMD) operating income changed +71.5% year-over-year on the latest annual filing.
When did Revolution Medicines operating income hit its highest annual value?
Revolution Medicines operating income reached its highest annual value of -$31.13M in 2017.
What was Revolution Medicines operating income in 2024?
Revolution Medicines (RVMD) operating income in 2024 was -$689.52M.
What was Revolution Medicines operating income in 2025?
Revolution Medicines (RVMD) operating income in 2025 was -$1.18B.
RVMD Key Financials
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
RVMD Overview
Company profile, financial tools, and key metrics
RVMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RVMD How It Makes Money
Discover visual breakdown — where revenue comes from and where it goes.
RVMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RVMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RVMD Daily Price Character
Explosive · 50.7% historical win rate (green days). Streaks & record days.
RVMD Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.